Drugs / Autologous adipose tissue derived stromal cells
Autologous adipose tissue derived stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05484856 | May 2016 → Jun 2020 | osteoarthritis, knee | Dr. Himanshu Bansal Foundation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous adipose tissue derived stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05484856 ↗ |
| Known as | ADSC | “Patients with Osteoarthritis A total of 140 patients ( May 2016 to june 2020) were treated with intra articular adipose derived stromal cells (ADSC)) also known as Stromal...” NCT05484856 ↗ |
| Known as | ASCs | “This isolation process yielded an abundant population of Adipose stromal cells(ASCs) which have multipotent differentiation potential.” NCT05484856 ↗ |
| Known as | stromal vascular fraction | “The potential of adult mesenchymal stem cells (MSCs) and adipose derived stromal cells fraction also known as stromal vascular fraction has recently being evaluated for...” NCT05484856 ↗ |